logo-loader

Q BioMed appoints ophthalmologist Dr Rajendra Apte to its advisory board

Last updated: 15:45 17 Sep 2018 BST, First published: 15:26 17 Sep 2018 BST

Rajendra Apte
Apte is a distinguished professor of ophthalmology and visual sciences at Washington University in St Louis

QBioMed Inc (OTCMKTS:QBIO) announced Monday that the ophthalmologist Dr Rajendra Apte has joined its advisory board.

A distinguished professor of ophthalmology and visual sciences at Washington University in St Louis, Apte is now in charge of a study to investigate the correlation of levels of the bio-marker GDF-15 with the severity and progression of glaucoma.

Read: QBioMed extends clinical trial agreement to study glaucoma drugs with Washington University

In a statement, Q BioMed’s CEO Denis Corin, said Apte’s expertise in ophthalmology will help the company’s efforts to advance the development of MAN-01, a small molecule eye-drop for the treatment of primary open angle glaucoma, and its potential companion diagnostic, GDF-15, a biomarker used to detect the severity of glaucoma.

“We are honored to have Dr Apte join our distinguished team of scientific advisors,” Corin said.

Apte’s other areas of specialty include age-related macular degeneration, diabetic retinopathy, vascular diseases, retinal surgery and retinal neurodegeneration.

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

43 minutes ago